[Progress in therapy for testicular tumors].

Dept. of Urology, Kyoto Prefectural University of Medicine.

Gan to kagaku ryoho. Cancer & chemotherapy. 2006;(2):183-7

Abstract

Approximately 80% of patients with metastatic testicular tumors are cured by cisplatin-containing chemotherapy and surgery. However, the remaining 20% of patients with advanced testicular tumors can not be cured at present. Thus, therapy for these testicular tumors infractory to treatment is the most important issue. Recently, chemotherapy for such tumors is developing, especially salvage chemotherapy using novel anticancer agents(paclitaxel, gemcitabine,irinotecan, docetaxel, oxaliplatin, etc) and high-dose anticancer drugs. Some of the new modalities are very attractive. In this article, we reviewed mainly these new forms of chemotherapy for testicular tumors.

Methodological quality

Publication Type : Review

Metadata